Gilead Sciences is an American biotechnology company that discovers, develops and commercializes therapeutics. For many years since the company was founded, the company concentrated primarily on antiviral drugs to treat patients infected with HIV, hepatitis B, or influenza. The company had 2010 revenue of US$7.95 billion and 4,000 employees.
Chazey Partners reviewed and corrected issues with the Finance Shared Services Center in Ireland, reviewed and optimized the European human resources Shared Services center in Stockley Park, UK, and produced a detailed review, a complete assessment and recommendations for the global finance function. This was a very complex assignment where the team corrected issues related to the prior “technical” style Shared Services deployment that was weak on governance and change management, including issues with the transition from a JD Edwards to an Oracle ERP. Additional complexity was added by the multiple locations/countries, significant change management, organizational design, people evaluation, training, and establishment of a new client relationship management framework. This Shared Services Transformation review and implementation project also included process mapping/design, business analysis, benchmarking and best practice analysis.